SCHEMBL71779

SCHEMBL71779

C1=NCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1018939 1.00
SCHEMBL9646 1.00
SCHEMBL9720250 1.00
SCHEMBL9325605 0.97
Hydrochloric Acid SCHEMBL324840 0.97
SCHEMBL5694752 0.97
Ammonia Solution, Strong SCHEMBL209038 0.97
Ammonia Solution, Strong SCHEMBL16861381 0.97
SCHEMBL10401525 0.97
SCHEMBL2287459 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 535 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008073450-A2 BENZAMIDE COMPOUNDS GEORGETOWN UNIVERSITY (US) 2008-06-19 WO claimed
US-20060194814-A1 Benzamide compounds GEORGETOWN UNIVERSITY 2006-08-31 US claimed
US-20060194815-A1 Methods and compositions for modulating serum cortisol levels GEORGETOWN UNIVERSITY 2006-08-31 US claimed
WO-2005112922-A9 BENZAMIDE COMPOUNDS SAMARITAN PHARMACEUTICALS (US) 2006-03-09 WO claimed
WO-2005112922-A2 BENZAMIDE COMPOUNDS SAMARITAN PHARMACEUTICALS (US) 2005-12-01 WO claimed
EP-1208089-B1 DIAZOCIN-DIONE DERIVATIVES AND THEIR USE AS TRYPTASE INHIBITORS ALTANA PHARMA AG (DE) 2004-10-13 EP claimed
EP-1216236-A1 TRYPTASE INHIBITORS Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 2002-06-26 EP claimed
EP-1208089-A2 DIAZOCIN-DIONE DERIVATIVES AND THEIR USE AS TRYPTASE INHIBITORS Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 2002-05-29 EP claimed
EP-1115731-A2 NOVEL PYRANOSES Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 2001-07-18 EP claimed
WO-2001019809-A1 TRYPTASE INHIBITORS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 2001-03-22 WO claimed
WO-2001010848-A2 DIAZOCIN-DIONE DERIVATIVES AND THEIR USE S TRYPTASE INHIBITORS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 2001-02-15 WO claimed
WO-2000014097-A2 NOVEL PYRANOSES BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 2000-03-16 WO claimed
EP-0934293-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH TRYPTASE ACTIVITY ARRIS PHARMACEUTICAL CORPORATION (US) 1999-08-11 EP claimed
WO-1998004537-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH TRYPTASE ACTIVITY ARRIS PHARMACEUTICAL CORPORATION (US) 1998-02-05 WO claimed
EP-0159011-B1 CEPHALOSPORIN DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DAIICHI SEIYAKU CO., LTD. (JP) 1989-08-02 EP claimed
US-4833242-A ANTIBIOTICS, BACTERICIDES DAIICHI SEIYAKU CO., LTD. (JP) 1989-05-23 US claimed
EP-4399202-A1 SUBSTITUTED QUINOLINES AS IMPROVED NF-KB-INDUCING KINASE (NIK) INHIBITORS Yukin Therapeutics (FR) 2024-07-17 EP disclosed
CN-118055934-A PARG inhibitory compounds 福克斯治疗股份公司 2024-05-17 CN disclosed
US-4833242-A ANTIBIOTICS, BACTERICIDES DAIICHI SEIYAKU CO., LTD. (JP) 1989-05-23 US disclosed
EP-0159011-A2 Cephalosporin derivatives, process for preparing them and pharmaceutical compositions containing them DAIICHI SEIYAKU CO., LTD. (JP) 1985-10-23 EP disclosed